Skip to main content

Intuitive Surgical stock price and financials

  • ISRG · Nasdaq
  • Medical devices
  • Health Care Equipment
  • S&P 500
$443.59+0.84%Close 13 Nov 2026
Market value
$152.6B
P/E
51.61
EV / EBITDA
36.35
Beta · 1 year
0.90
Return · 1 year
−22.5%
52-week range$328.57 — $603.88

Share price close 16 Nov 2026

+2.8%1 monthHigh $482.10Low $426.70
$420$440$460$480$500Q3 FY2026 report filed 21 Oct 202623 Oct29 Oct4 Nov10 Nov16 Nov
+4.5%6 monthsHigh $482.10Low $332.02
$300$350$400$450$500Q2 FY2026 report filed 21 Jul 2026Q3 FY2026 report filed 21 Oct 20264 Jun2 Jul30 Jul26 Aug23 Sep20 Oct16 Nov
−22.3%year to dateHigh $592.85Low $332.02
$300$400$500$600Q4 FY2025 report filed 3 Feb 2026Q1 FY2026 report filed 22 Apr 2026Q2 FY2026 report filed 21 Jul 2026Q3 FY2026 report filed 21 Oct 202611 Feb30 Mar14 May1 Jul17 Aug1 Oct16 Nov
−19.9%1 yearHigh $592.85Low $332.02
$300$400$500$600Q4 FY2025 report filed 3 Feb 2026Q1 FY2026 report filed 22 Apr 2026Q2 FY2026 report filed 21 Jul 2026Q3 FY2026 report filed 21 Oct 2026Jan 26Mar 26Apr 26Jun 26Aug 26Sep 26Nov 26
+50.0%3 yearsHigh $610.45Low $303.95
$300$400$500$600$700Q4 FY2023 report filed 31 Jan 2024Q1 FY2024 report filed 19 Apr 2024Q2 FY2024 report filed 19 Jul 2024Q3 FY2024 report filed 18 Oct 2024Q4 FY2024 report filed 31 Jan 2025Q1 FY2025 report filed 23 Apr 2025Q2 FY2025 report filed 23 Jul 2025Q3 FY2025 report filed 22 Oct 2025Q4 FY2025 report filed 3 Feb 2026Q1 FY2026 report filed 22 Apr 2026Q2 FY2026 report filed 21 Jul 2026Q3 FY2026 report filed 21 Oct 2026Apr 24Sep 24Feb 25Aug 25Jan 26Jun 26Nov 26
+505%10 yearsHigh $610.45Low $69.47
$0$200$400$600$800Apr 18Sep 19Feb 21Jul 22Jan 24Jun 25Nov 26

Quarterly or annual report filed

In one paragraph

Intuitive Surgical reported revenue of $10.1 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 20.5% from fiscal 2024. Net income was $2.86 billion and diluted earnings per share $7.87.

In its latest reported quarter, the third quarter of fiscal 2026 (the three months to 30 Sep 2026), revenue was $3.05 billion, up 21.7% from a year earlier.

Figures from Intuitive Surgical's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 21 Oct 2026.

Against Health Care

Growth
Top 10%
Revenue +18.2% a year over five years · 3rd of 37
Profitability
Top quarter
Return on invested capital 19.3%, five-year average · 8th of 38
Balance sheet
Top quarter
More cash than debt · 7th of 38
Valuation
Dearer than most
P/E 51.6 · 31st of 36

Among the sector's S&P 500 members with the figure; the longer the bar, the better placed. Debt and P/E rank lower first.

Revenue FY2025
$10.06B+20.5%
Net income
$2.86B+23.0%
Diluted EPS
$7.87+22.6%
Gross margin
66.0%−1.5 pts
Free cash flow
$2.49B+91.0%

Fiscal 2025 against fiscal 2024; bars show the last 10 fiscal years.

Revenue and net income fiscal 2016–2025

  • Revenue
  • Net income
$0$2.5B$5B$7.5B$10B$12.5BRevenue, FY16: $2.7BNet income, FY16: $738.3MFY16Revenue, FY17: $3.14BNet income, FY17: $670.9MFY17Revenue, FY18: $3.72BNet income, FY18: $1.13BFY18Revenue, FY19: $4.48BNet income, FY19: $1.38BFY19Revenue, FY20: $4.36BNet income, FY20: $1.06BFY20Revenue, FY21: $5.71BNet income, FY21: $1.7BFY21Revenue, FY22: $6.22BNet income, FY22: $1.32BFY22Revenue, FY23: $7.12BNet income, FY23: $1.8BFY23Revenue, FY24: $8.35BNet income, FY24: $2.32BFY24Revenue, FY25: $10.06BNet income, FY25: $2.86BFY25

Latest quarter · Q3 FY2026 to 30 Sep 2026, filed 21 Oct 2026 · Full results →

Revenue
$3.05B+21.7% on a year
Gross margin
68.4%+2.0 pts on a year
Operating income
$592.6M−22.0% on a year
Net income
$522.8M−25.8% on a year
Diluted EPS
$1.49−23.6% on a year
Free cash flow
$1.11B+51.0% on a year

Comparable companies All of Health Care →

Intuitive Surgical beside the other S&P 500 members in Health Care Equipment, by market value.

Intuitive Surgical and comparable companies
CompanyMarket valueDay1 yearRevenue growthNet marginP/E
Intuitive SurgicalISRG$152.6B+0.8%−22.5%+20.5%25.5%51.6
Abbott LaboratoriesABT$188.1B+1.2%−15.8%+10.0%9.7%40.0
Boston ScientificBSX$63.86B+0.3%−57.4%+8.9%16.6%18.2
Edwards LifesciencesEW$61.47B+1.3%+25.2%+13.4%15.3%60.2
Becton DickinsonBDX$59.14B+1.1%+44.4%−2.6%4.5%62.9
Idexx LaboratoriesIDXX$55.78B+0.9%−1.3%+11.9%25.4%47.2
GE HealthCareGEHC$37.71B+1.4%+10.7%+6.9%10.0%17.5

Market value and moves at the latest close. Revenue growth compares the last twelve months with the twelve before; net margin and P/E over the last twelve months; P/E is left blank where earnings are negative.

Margins fiscal 2016–2025

  • Gross
  • Operating
  • Net
0%25%50%75%66.0%29.3%28.4%FY16FY19FY22FY25

Intuitive Surgical revenue by segment, product and region

Fiscal years, as the company cuts its revenue in its annual reports; the change on a year under each figure. A change is left out from a loss, from a sliver of revenue, or across a change in how the company reports.

By product

Intuitive Surgical revenue by product, by fiscal year
RevenueFY 2021FY 2022FY 2023FY 2024FY 2025
Instruments and accessories$3.10B$3.52B+13.5%$4.28B+21.6%$5.08B+18.8%$6.02B+18.5%
Systems$1.69B$1.68B−0.8%$1.68B−0.0%$1.97B+17.0%$2.47B+25.8%
Service$916.2M$1.02B+11.8%$1.17B+14.0%$1.31B+11.9%$1.57B+20.3%
Total revenue$5.71B$6.22B$7.12B$8.35B$10.06B

Financial statements

Fiscal years, the latest ending 31 Dec 2025. Amounts in USD. On a narrow screen the table opens on the latest year and scrolls back.

Income statement

Intuitive Surgical income statement, annual
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue$2.70B$3.14B$3.72B$4.48B$4.36B$5.71B$6.22B$7.12B$8.35B$10.06B
Revenue growth+13.4%+16.0%+18.7%+20.3%−2.7%+31.0%+9.0%+14.5%+17.2%+20.5%
Gross profit$1.89B$2.20B$2.60B$3.11B$2.86B$3.96B$4.20B$4.73B$5.63B$6.64B
Operating income$949.7M$1.06B$1.20B$1.37B$1.05B$1.82B$1.58B$1.77B$2.35B$2.95B
Net income$738.3M$670.9M$1.13B$1.38B$1.06B$1.70B$1.32B$1.80B$2.32B$2.86B
Diluted EPS$2.09$1.92$3.16$3.85$2.94$4.66$3.65$5.03$6.42$7.87
Gross margin70.0%70.2%69.9%69.4%65.6%69.3%67.4%66.4%67.5%66.0%
Operating margin35.1%33.9%32.2%30.7%24.1%31.9%25.3%24.8%28.1%29.3%
Net margin27.3%21.4%30.3%30.8%24.3%29.9%21.3%25.2%27.8%28.4%

Cash flow

Intuitive Surgical cash flow, annual
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Operating cash flow$1.09B$1.14B$1.17B$1.60B$1.48B$2.09B$1.49B$1.81B$2.42B$3.03B
Capital expenditure$53.90M$190.7M$187.4M$425.6M$341.5M$339.5M$532.4M$1.06B$1.11B$539.8M
Free cash flow$1.03B$953.2M$982.2M$1.17B$1.14B$1.75B$958.4M$749.6M$1.30B$2.49B

Balance sheet and shares

Intuitive Surgical balance sheet and shares, annual
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash and equivalents$1.04B$648.2M$857.9M$1.17B$1.62B$1.29B$1.58B$2.75B$2.03B$3.37B
Total debt$0.00$0.00————————
Shareholders' equity$5.78B$4.78B$6.68B$8.26B$9.73B$11.90B$11.04B$13.31B$16.43B$17.82B
Diluted shares354M349M356M358M361M366M362M357M362M363M

Quarterly figures

The last eight fiscal quarters, the latest ending 30 Sep 2026. Year-on-year growth compares the same quarter of the previous fiscal year.

Intuitive Surgical quarterly financial figures
PeriodQ4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$2.41B$2.25B$2.44B$2.51B$2.87B$2.77B$2.89B$3.05B
Revenue, year on year+25.2%+19.2%+21.4%+22.9%+18.8%+23.0%+18.5%+21.7%
Gross margin68.0%64.7%66.3%66.4%66.4%66.1%67.8%68.4%
Operating income$734.9M$578.1M$743.4M$759.7M$864.3M$855.3M$971.9M$592.6M
Net income$685.7M$698.4M$658.4M$704.4M$794.8M$821.5M$818.1M$522.8M
Diluted EPS$1.88$1.92$1.81$1.95$2.21$2.28$2.29$1.49
Free cash flow$510.6M$465.0M$560.1M$735.6M$730.0M$808.6M$948.4M$1.11B

Operating KPIs

The operating figures Intuitive Surgical reports beside its statements, then its revenue by product, segment and region, latest period first. Each links to its full history.

Intuitive Surgical operating KPIs
KPILatestPeriodChange on a yearRecent periods
U.S. unit placements (Da Vinci Surgical System Placements)335quarter to 30 Sep 2026up 27.4%
OUS unit placements (Da Vinci Surgical System Placements)211quarter to 30 Sep 2026up 28.7%
Total unit placements (Da Vinci Surgical System Placements)546quarter to 30 Sep 2026up 27.9%
Unit placements involving trade-ins or lease upgrades (Da Vinci Surgical System Placements involving Trade-ins or Lease Upgrades)141quarter to 30 Sep 2025up 271.1%
Remaining performance obligations$3.0Bat 31 Dec 2025—
Product revenue$2.6Bquarter to 30 Sep 2026up 21.7%
Instruments and accessories revenue$1.8Bquarter to 30 Sep 2026up 18.3%
Systems revenue$769.1Mquarter to 30 Sep 2026up 30.3%
Service revenue$482.2Mquarter to 30 Sep 2026up 21.8%

Method

Each period is read from the report the company filed and checked against accounting identities before it is shown; a figure that does not pass is left blank rather than estimated. Free cash flow is operating cash flow less capital expenditure. Fiscal years follow the company's own calendar. See data and methodology.

The same figures as plain text and JSON.

Questions

What was Intuitive Surgical's revenue in fiscal 2025?

$10.1 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), as reported in its annual report.

What was Intuitive Surgical's net income in fiscal 2025?

$2.86 billion for fiscal year 2025 (the twelve months to 31 Dec 2025).

What were Intuitive Surgical's diluted earnings per share in fiscal 2025?

$7.87 for fiscal year 2025 (the twelve months to 31 Dec 2025).

What is Intuitive Surgical's gross margin?

66.0% for fiscal year 2025 (the twelve months to 31 Dec 2025): gross profit divided by revenue.

What is Intuitive Surgical's operating margin?

29.3% for fiscal year 2025 (the twelve months to 31 Dec 2025): operating income divided by revenue.

How much free cash flow did Intuitive Surgical generate in fiscal 2025?

$2.49 billion for fiscal year 2025 (the twelve months to 31 Dec 2025): operating cash flow less capital expenditure.

Where does Intuitive Surgical's revenue come from?

In fiscal 2025, by product: Instruments and accessories $6.02B (60%), Systems $2.47B (25%), Service $1.57B (16%), out of $10.06B in all, as stated in its annual report.

In the terminal

Twenty years of Intuitive Surgical's figures, KPIs, guidance and a cash-flow valuation.

  • Every report line and operating figure, quarter by quarter
  • Guidance against what was delivered
  • Insider trades and institutional holders
  • Alerts on results, filings and price
See plans